Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 75Years
All Genders
NCT07038343

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Led by Avenzo Therapeutics, Inc. · Updated on 2026-05-13

480

Participants Needed

18

Research Sites

286 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-1418 when administered intravenously as a monotherapy and potentially in combination therapy to patients with locally advanced or metastatic epithelial solid tumors.

CONDITIONS

Official Title

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 75 years with ECOG Performance Status of 0 or 1 and life expectancy over 3 months
  • Histologically or cytologically confirmed locally advanced or metastatic epithelial solid tumors as specified in the protocol
  • Measurable disease by RECIST v1.1 assessment
  • Willingness to provide molecular test reports and tumor samples or fresh biopsy
  • Other protocol-defined inclusion criteria
Not Eligible

You will not qualify if you...

  • Uncontrolled high blood pressure
  • Active central nervous system metastases; treated, stable brain metastases without steroid treatment are allowed
  • Suspected or confirmed leptomeningeal disease
  • History of drug-induced interstitial lung disease
  • History of serious cardiovascular conditions
  • Infection requiring IV antibiotics, antivirals, or antifungals within 2 weeks before first dose
  • History of solid organ transplant
  • Other protocol-defined exclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 18 locations

1

Avenzo Therapeutics Recruiting Site

Gilbert, Arizona, United States, 85234

Actively Recruiting

2

Avenzo Therapeutics Recruiting Site

Los Angeles, California, United States, 90048

Actively Recruiting

3

Avenzo Therapeutics Recruiting Site

Denver, Colorado, United States, 80218

Actively Recruiting

4

Avenzo Therapeutics Recruiting Site

New Haven, Connecticut, United States, 06510

Actively Recruiting

5

Avenzo Therapeutics Recruiting Site

Washington D.C., District of Columbia, United States, 20007

Actively Recruiting

6

Avenzo Therapeutics Recruiting Site

Orlando, Florida, United States, 32827

Actively Recruiting

7

Avenzo Therapeutics Recruiting Site

Sarasota, Florida, United States, 34232

Actively Recruiting

8

Avenzo Therapeutics Recruiting Site

Tampa, Florida, United States, 33612

Actively Recruiting

9

Avenzo Therapeutics Recruiting Site

Atlanta, Georgia, United States, 30322

Actively Recruiting

10

Avenzo Therapeutics Recruiting Site

Boston, Massachusetts, United States, 02215

Actively Recruiting

11

Avenzo Therapeutics Recruiting Site

New York, New York, United States, 10029

Actively Recruiting

12

Avenzo Therapeutics Recruiting Site

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

13

Avenzo Therapeutics Recruiting Site

Dallas, Texas, United States, 75039

Actively Recruiting

14

Avenzo Therapeutics Recruiting Site

Houston, Texas, United States, 77054

Actively Recruiting

15

Avenzo Therapeutics Recruiting Site

San Antonio, Texas, United States, 78229

Actively Recruiting

16

Avenzo Therapeutics Recruiting Site

West Valley City, Utah, United States, 84119

Actively Recruiting

17

Avenzo Therapeutics Recruiting Site

Fairfax, Virginia, United States, 22031

Actively Recruiting

18

Avenzo Therapeutics Recruiting Site

Seattle, Washington, United States, 98109

Actively Recruiting

Loading map...

Research Team

M

Medical Information

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here